Cargando…
Editorial: Repurposed Drugs Targeting Cancer Signaling Pathways: Clinical Insights to Improve Oncologic Therapies
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8269316/ https://www.ncbi.nlm.nih.gov/pubmed/34249767 http://dx.doi.org/10.3389/fonc.2021.713040 |
| _version_ | 1783720551994359808 |
|---|---|
| author | Pérez-Plasencia, Carlos Padilla-Benavides, Teresita López-Urrutia, Eduardo Campos-Parra, Alma D. |
| author_facet | Pérez-Plasencia, Carlos Padilla-Benavides, Teresita López-Urrutia, Eduardo Campos-Parra, Alma D. |
| author_sort | Pérez-Plasencia, Carlos |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8269316 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-82693162021-07-10 Editorial: Repurposed Drugs Targeting Cancer Signaling Pathways: Clinical Insights to Improve Oncologic Therapies Pérez-Plasencia, Carlos Padilla-Benavides, Teresita López-Urrutia, Eduardo Campos-Parra, Alma D. Front Oncol Oncology Frontiers Media S.A. 2021-06-23 /pmc/articles/PMC8269316/ /pubmed/34249767 http://dx.doi.org/10.3389/fonc.2021.713040 Text en Copyright © 2021 Pérez-Plasencia, Padilla-Benavides, López-Urrutia and Campos-Parra https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Oncology Pérez-Plasencia, Carlos Padilla-Benavides, Teresita López-Urrutia, Eduardo Campos-Parra, Alma D. Editorial: Repurposed Drugs Targeting Cancer Signaling Pathways: Clinical Insights to Improve Oncologic Therapies |
| title | Editorial: Repurposed Drugs Targeting Cancer Signaling Pathways: Clinical Insights to Improve Oncologic Therapies |
| title_full | Editorial: Repurposed Drugs Targeting Cancer Signaling Pathways: Clinical Insights to Improve Oncologic Therapies |
| title_fullStr | Editorial: Repurposed Drugs Targeting Cancer Signaling Pathways: Clinical Insights to Improve Oncologic Therapies |
| title_full_unstemmed | Editorial: Repurposed Drugs Targeting Cancer Signaling Pathways: Clinical Insights to Improve Oncologic Therapies |
| title_short | Editorial: Repurposed Drugs Targeting Cancer Signaling Pathways: Clinical Insights to Improve Oncologic Therapies |
| title_sort | editorial: repurposed drugs targeting cancer signaling pathways: clinical insights to improve oncologic therapies |
| topic | Oncology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8269316/ https://www.ncbi.nlm.nih.gov/pubmed/34249767 http://dx.doi.org/10.3389/fonc.2021.713040 |
| work_keys_str_mv | AT perezplasenciacarlos editorialrepurposeddrugstargetingcancersignalingpathwaysclinicalinsightstoimproveoncologictherapies AT padillabenavidesteresita editorialrepurposeddrugstargetingcancersignalingpathwaysclinicalinsightstoimproveoncologictherapies AT lopezurrutiaeduardo editorialrepurposeddrugstargetingcancersignalingpathwaysclinicalinsightstoimproveoncologictherapies AT camposparraalmad editorialrepurposeddrugstargetingcancersignalingpathwaysclinicalinsightstoimproveoncologictherapies |